By Dr Bashir A. Malik
In current booming epidemic of SARS-CoV-2 various government authorities and private or independent researchers are coming up with protocol for management of COVID 19. Here we have a protocol describe by the author for COVID 19.
Dr Bashir A Malik an independent researcher had made an attempt with his previous experience of working in research with these ultra high dilution medicines. The author has clinically established Bacillinum (Koch) very efficacious in rectifying the underlying genetic predisposition and restoration of necrosed lung tissue with large cavities and hemoptysis. Bacillinum (Koch) is generally indicated especially for lung diseases of old people, but the author found it equally efficacious to fight predisposition of allergic rhinitis, pneumonia and asthma in young ones.
Click the below link for accessing the document and for further clarification can contact the author -
H/Dr. Bashir A. Malik
D. Biochemistry (London)
D.Hom (London), F.BFS (London)
Link - 1 - https://www.researchgate.net/publication/339847373_COVID-19_ADDENDUM_TO_Suggested_Homoeopathic_Treatment_for_Coronavirus_Established_Cases
Link - 2 -https://www.researchgate.net/publication/339586244_COVID-19_-_Suggested_Homoeopathic_Treatment_for_Coronavirus_Established_Cases